2024 Q4 Form 10-K Financial Statement

#000143774924032441 Filed on October 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $36.87K
YoY Change -40.63%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $74.60K $36.87K $158.9K
YoY Change 26.83% -40.63% -12.56%
Operating Profit -$74.60K -$158.9K
YoY Change 26.83% -12.56%
Interest Expense $2.860K -$2.850K $11.45K
YoY Change -0.35% 18.75% 59.26%
% of Operating Profit
Other Income/Expense, Net -$2.860K $0.00 -$11.45K
YoY Change -0.35% -105.58%
Pretax Income -$77.46K -$39.72K -$170.3K
YoY Change 25.57% -127.22% -824.91%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$77.46K -$39.72K -$170.3K
YoY Change 25.57% -127.22% -824.91%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 105.8M 94.51M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.14K $53.14K
YoY Change 670.14% 670.14%
Cash & Equivalents $10.66K $53.14K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.66K $53.14K $53.14K
YoY Change 406.51% 670.13% 670.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.66K $53.14K $53.14K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $10.66K $53.14K $53.14K
YoY Change 406.51% 670.13% 670.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.600K $1.600K
YoY Change -97.71% -97.71%
Accrued Expenses $35.09K $33.51K $33.51K
YoY Change 22.07% 23.4% 23.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $86.00K $86.00K
YoY Change
Total Short-Term Liabilities $137.1K $121.1K $121.1K
YoY Change -33.74% -54.81% -54.81%
LONG-TERM LIABILITIES
Long-Term Debt $85.00K $85.00K
YoY Change
Other Long-Term Liabilities $64.86K $64.86K
YoY Change
Total Long-Term Liabilities $149.9K $149.9K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $137.1K $121.1K $121.1K
Total Long-Term Liabilities $149.9K $149.9K
Total Liabilities $287.0K $271.0K $271.0K
YoY Change -1.7% 1.1% 1.11%
SHAREHOLDERS EQUITY
Retained Earnings -$3.616M -$3.538M
YoY Change 5.43% 5.06%
Common Stock $105.4K $105.3K
YoY Change 18.35% 18.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$276.3K -$217.8K -$217.8K
YoY Change
Total Liabilities & Shareholders Equity $10.66K $53.14K $53.14K
YoY Change 406.51% 670.13% 670.14%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024
OPERATING ACTIVITIES
Net Income -$77.46K -$39.72K -$170.3K
YoY Change 25.57% -127.22% -824.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$42.48K -$43.81K -$167.4K
YoY Change 12.39% 20.36% 14.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 55.00K $213.6K
YoY Change -100.0% 48.65% 68.21%
NET CHANGE
Cash From Operating Activities -$42.48K -43.81K -$167.4K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $0.00 55.00K $213.6K
Net Change In Cash -$42.48K 11.19K $46.24K
YoY Change 785.86% 1765.0% -344.48%
FREE CASH FLOW
Cash From Operating Activities -$42.48K -$43.81K -$167.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
210453 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
205207 usd
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024Q3 us-gaap Assets Current
AssetsCurrent
53139 usd
CY2024Q3 us-gaap Assets
Assets
53139 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33506 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
121106 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
183016 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-170340 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
23498 usd
CY2024 us-gaap Interest Expense
InterestExpense
11454 usd
CY2023 us-gaap Other Income
OtherIncome
1946 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11454 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-170340 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23498 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001415744
CY2024 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
10122200 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105801032
CY2024 dei Auditor Name
AuditorName
Haynie & Company
CY2024 dei Auditor Location
AuditorLocation
Salt Lake City, Utah
CY2024 dei Auditor Firm
AuditorFirmId
457
CY2024Q3 us-gaap Cash
Cash
53139 usd
CY2023Q3 us-gaap Cash
Cash
6900 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
6900 usd
CY2023Q3 us-gaap Assets
Assets
6900 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27152 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
86000 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
86000 usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
85000 usd
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
85000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
270970 usd
CY2023Q3 us-gaap Liabilities
Liabilities
268016 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105301032
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105301032
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89059357
CY2023 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4333334
CY2023 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
85000 usd
CY2023Q3 nmex Common Stock Shares Not Issued
CommonStockSharesNotIssued
333334
CY2023Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
450000
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.015
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
6750 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-35800 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4900 usd
CY2024 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0 usd
CY2023 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-37700 usd
CY2024 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
35800 usd
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
32800 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89059357
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
105301 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
89059 usd
CY2024Q3 nmex Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2023Q3 nmex Common Stock To Be Issued
CommonStockToBeIssued
30000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3215051 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2987668 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3538183 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3367843 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-217831 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-261116 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53139 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6900 usd
CY2024 us-gaap Officers Compensation
OfficersCompensation
26400 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
39150 usd
CY2024 nmex Related Party Consulting Expenses
RelatedPartyConsultingExpenses
76700 usd
CY2023 nmex Related Party Consulting Expenses
RelatedPartyConsultingExpenses
72000 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
33850 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
27150 usd
CY2024 nmex Director Services Expenses
DirectorServicesExpenses
0 usd
CY2023 nmex Director Services Expenses
DirectorServicesExpenses
11250 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21936 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32159 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
158886 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
181709 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-158886 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-181709 usd
CY2023 us-gaap Interest Expense
InterestExpense
7192 usd
CY2024 us-gaap Other Income
OtherIncome
0 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
23498 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94508628
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82759357
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-435364 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-261116 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-170340 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-217831 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-170340 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
23498 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
210453 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6354 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7192 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-167386 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145913 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
7000 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000 usd
CY2024 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213625 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
127000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46239 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18913 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6900 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25813 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53139 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6900 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
3825 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Use of estimates</span></i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3538183 usd
CY2022 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
15000 usd
CY2023Q3 us-gaap Unsecured Debt
UnsecuredDebt
7000 usd
CY2024Q3 us-gaap Unsecured Debt
UnsecuredDebt
11000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
153500 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
148800 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
153500 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
148800 usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
586000 usd
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure

Files In Submission

Name View Source Status
0001437749-24-032441-index-headers.html Edgar Link pending
0001437749-24-032441-index.html Edgar Link pending
0001437749-24-032441.txt Edgar Link pending
0001437749-24-032441-xbrl.zip Edgar Link pending
ex_734371.htm Edgar Link pending
ex_734372.htm Edgar Link pending
ex_734373.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nmex-20240731.xsd Edgar Link pending
nmex20240731_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nmex-20240731_def.xml Edgar Link unprocessable
nmex-20240731_cal.xml Edgar Link unprocessable
nmex-20240731_pre.xml Edgar Link unprocessable
nmex-20240731_lab.xml Edgar Link unprocessable
nmex20240731_10k_htm.xml Edgar Link completed